Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Key takeaways:
METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million
The company was incubated by AI pharmaceutical unicorn XtaiPl, whose most recent valuation exceeded $2.05 billion
By Molly Wen
Companies Reporting Before The Bell
• 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Kala Pharmaceuticals (NASDAQ:KALA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results.
How to Attend Kala Pharmaceuticals (KALA) Conference Call
Follow this link to access the live webcast.
Gainers
Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday.
TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.